A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Regorafenib 13CD3 | CAS 2126178-55-8 - Request Quote

Picture of Regorafenib 13CD3

Regorafenib 13CD3

SZ CAT No:SZ-R039D03
CAS No
2126178-55-8
Mol.F.
C2013CH12D3ClF4N4O3
Mol.Wt.
486.8
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Regorafenib 13CD3 is chemically 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-(methyl-13C-d3)picolinamide. Regorafenib 13CD3 is supplied with detailed characterization data compliant with regulatory guideline. Regorafenib 13CD3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Regorafenib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2126178-55-8

Purchase 2126178-55-8

Order 2126178-55-8

Enquire 2126178-55-8

price of 2126178-55-8

2126178-55-8 Supplier

2126178-55-8 Manufacturer

2126178-55-8 Exporter

buy high quality Regorafenib 13CD3

Purchase Regorafenib 13CD3

Regorafenib 13CD3 suppliers

Regorafenib 13CD3 manufacturers

Regorafenib 13CD3 price

Order Regorafenib 13CD3

Enquire Regorafenib 13CD3

Regorafenib 13CD3 cost

Regorafenib 13CD3 Supplier

Regorafenib 13CD3 Distributor

Regorafenib 13CD3 for Method Validation

Regorafenib Reference Standard

Regorafenib 13CD3 for ANDA Filing

Regorafenib 13CD3 for Forced Degradation Studies

Regorafenib 13CD3 Identification Standards

Regorafenib 13CD3 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,